 | • レポートコード：MRC2312MG14132 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のGLP-1減量薬市場規模と予測を収録しています。・世界のGLP-1減量薬市場：売上、2018年-2023年、2024年-2029年 ・世界のGLP-1減量薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のGLP-1減量薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「注射剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 GLP-1減量薬のグローバル主要企業は、Novo Nordisk、 AstraZeneca、 Eli Lilly、 Sanofi、 BENEMAE、 HANSOH PHARMLA、 CHIATAI TIANQING、 Tonghua Dongbao Pharmaceutical、 Huadong Medicineなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、GLP-1減量薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のGLP-1減量薬市場：タイプ別、2018年-2023年、2024年-2029年 世界のGLP-1減量薬市場：タイプ別市場シェア、2022年 ・注射剤、経口剤 世界のGLP-1減量薬市場：用途別、2018年-2023年、2024年-2029年 世界のGLP-1減量薬市場：用途別市場シェア、2022年 ・オンライン薬局、オフライン薬局 世界のGLP-1減量薬市場：地域・国別、2018年-2023年、2024年-2029年 世界のGLP-1減量薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるGLP-1減量薬のグローバル売上、2018年-2023年 ・主要企業におけるGLP-1減量薬のグローバル売上シェア、2022年 ・主要企業におけるGLP-1減量薬のグローバル販売量、2018年-2023年 ・主要企業におけるGLP-1減量薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Novo Nordisk、 AstraZeneca、 Eli Lilly、 Sanofi、 BENEMAE、 HANSOH PHARMLA、 CHIATAI TIANQING、 Tonghua Dongbao Pharmaceutical、 Huadong Medicine ************************************************************* ・調査・分析レポートの概要 GLP-1減量薬市場の定義 市場セグメント 世界のGLP-1減量薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のGLP-1減量薬市場規模 世界のGLP-1減量薬市場規模：2022年 VS 2029年 世界のGLP-1減量薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのGLP-1減量薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のGLP-1減量薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：注射剤、経口剤 GLP-1減量薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：オンライン薬局、オフライン薬局 GLP-1減量薬の用途別グローバル売上・予測 ・地域別市場分析 地域別GLP-1減量薬市場規模 2022年と2029年 地域別GLP-1減量薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Novo Nordisk、 AstraZeneca、 Eli Lilly、 Sanofi、 BENEMAE、 HANSOH PHARMLA、 CHIATAI TIANQING、 Tonghua Dongbao Pharmaceutical、 Huadong Medicine ... |
This research report provides a comprehensive analysis of the GLP-1 Weight Loss Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global GLP-1 Weight Loss Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of GLP-1 Weight Loss Drug, challenges faced by the industry, and potential opportunities for market players.
The global GLP-1 Weight Loss Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The GLP-1 Weight Loss Drug market presents opportunities for various stakeholders, including Online Pharmacy, Offline Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in GLP-1 Weight Loss Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global GLP-1 Weight Loss Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the GLP-1 Weight Loss Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the GLP-1 Weight Loss Drug market.
Market Overview: The report provides a comprehensive overview of the GLP-1 Weight Loss Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Injection, Oral), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the GLP-1 Weight Loss Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the GLP-1 Weight Loss Drug market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the GLP-1 Weight Loss Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the GLP-1 Weight Loss Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the GLP-1 Weight Loss Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the GLP-1 Weight Loss Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for GLP-1 Weight Loss Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the GLP-1 Weight Loss Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
GLP-1 Weight Loss Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Injection
Oral
Market segment by Application
Online Pharmacy
Offline Pharmacy
Global GLP-1 Weight Loss Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Novo Nordisk
AstraZeneca
Eli Lilly
Sanofi
BENEMAE
HANSOH PHARMLA
CHIATAI TIANQING
Tonghua Dongbao Pharmaceutical
Huadong Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of GLP-1 Weight Loss Drug, market overview.
Chapter 2: Global GLP-1 Weight Loss Drug market size in revenue and volume.
Chapter 3: Detailed analysis of GLP-1 Weight Loss Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of GLP-1 Weight Loss Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global GLP-1 Weight Loss Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 GLP-1 Weight Loss Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global GLP-1 Weight Loss Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global GLP-1 Weight Loss Drug Overall Market Size
2.1 Global GLP-1 Weight Loss Drug Market Size: 2022 VS 2029
2.2 Global GLP-1 Weight Loss Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global GLP-1 Weight Loss Drug Sales: 2018-2029
3 Company Landscape
3.1 Top GLP-1 Weight Loss Drug Players in Global Market
3.2 Top Global GLP-1 Weight Loss Drug Companies Ranked by Revenue
3.3 Global GLP-1 Weight Loss Drug Revenue by Companies
3.4 Global GLP-1 Weight Loss Drug Sales by Companies
3.5 Global GLP-1 Weight Loss Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 GLP-1 Weight Loss Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers GLP-1 Weight Loss Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 GLP-1 Weight Loss Drug Players in Global Market
3.8.1 List of Global Tier 1 GLP-1 Weight Loss Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 GLP-1 Weight Loss Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global GLP-1 Weight Loss Drug Market Size Markets, 2022 & 2029
4.1.2 Injection
4.1.3 Oral
4.2 By Type – Global GLP-1 Weight Loss Drug Revenue & Forecasts
4.2.1 By Type – Global GLP-1 Weight Loss Drug Revenue, 2018-2023
4.2.2 By Type – Global GLP-1 Weight Loss Drug Revenue, 2024-2029
4.2.3 By Type – Global GLP-1 Weight Loss Drug Revenue Market Share, 2018-2029
4.3 By Type – Global GLP-1 Weight Loss Drug Sales & Forecasts
4.3.1 By Type – Global GLP-1 Weight Loss Drug Sales, 2018-2023
4.3.2 By Type – Global GLP-1 Weight Loss Drug Sales, 2024-2029
4.3.3 By Type – Global GLP-1 Weight Loss Drug Sales Market Share, 2018-2029
4.4 By Type – Global GLP-1 Weight Loss Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global GLP-1 Weight Loss Drug Market Size, 2022 & 2029
5.1.2 Online Pharmacy
5.1.3 Offline Pharmacy
5.2 By Application – Global GLP-1 Weight Loss Drug Revenue & Forecasts
5.2.1 By Application – Global GLP-1 Weight Loss Drug Revenue, 2018-2023
5.2.2 By Application – Global GLP-1 Weight Loss Drug Revenue, 2024-2029
5.2.3 By Application – Global GLP-1 Weight Loss Drug Revenue Market Share, 2018-2029
5.3 By Application – Global GLP-1 Weight Loss Drug Sales & Forecasts
5.3.1 By Application – Global GLP-1 Weight Loss Drug Sales, 2018-2023
5.3.2 By Application – Global GLP-1 Weight Loss Drug Sales, 2024-2029
5.3.3 By Application – Global GLP-1 Weight Loss Drug Sales Market Share, 2018-2029
5.4 By Application – Global GLP-1 Weight Loss Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global GLP-1 Weight Loss Drug Market Size, 2022 & 2029
6.2 By Region – Global GLP-1 Weight Loss Drug Revenue & Forecasts
6.2.1 By Region – Global GLP-1 Weight Loss Drug Revenue, 2018-2023
6.2.2 By Region – Global GLP-1 Weight Loss Drug Revenue, 2024-2029
6.2.3 By Region – Global GLP-1 Weight Loss Drug Revenue Market Share, 2018-2029
6.3 By Region – Global GLP-1 Weight Loss Drug Sales & Forecasts
6.3.1 By Region – Global GLP-1 Weight Loss Drug Sales, 2018-2023
6.3.2 By Region – Global GLP-1 Weight Loss Drug Sales, 2024-2029
6.3.3 By Region – Global GLP-1 Weight Loss Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America GLP-1 Weight Loss Drug Revenue, 2018-2029
6.4.2 By Country – North America GLP-1 Weight Loss Drug Sales, 2018-2029
6.4.3 US GLP-1 Weight Loss Drug Market Size, 2018-2029
6.4.4 Canada GLP-1 Weight Loss Drug Market Size, 2018-2029
6.4.5 Mexico GLP-1 Weight Loss Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe GLP-1 Weight Loss Drug Revenue, 2018-2029
6.5.2 By Country – Europe GLP-1 Weight Loss Drug Sales, 2018-2029
6.5.3 Germany GLP-1 Weight Loss Drug Market Size, 2018-2029
6.5.4 France GLP-1 Weight Loss Drug Market Size, 2018-2029
6.5.5 U.K. GLP-1 Weight Loss Drug Market Size, 2018-2029
6.5.6 Italy GLP-1 Weight Loss Drug Market Size, 2018-2029
6.5.7 Russia GLP-1 Weight Loss Drug Market Size, 2018-2029
6.5.8 Nordic Countries GLP-1 Weight Loss Drug Market Size, 2018-2029
6.5.9 Benelux GLP-1 Weight Loss Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia GLP-1 Weight Loss Drug Revenue, 2018-2029
6.6.2 By Region – Asia GLP-1 Weight Loss Drug Sales, 2018-2029
6.6.3 China GLP-1 Weight Loss Drug Market Size, 2018-2029
6.6.4 Japan GLP-1 Weight Loss Drug Market Size, 2018-2029
6.6.5 South Korea GLP-1 Weight Loss Drug Market Size, 2018-2029
6.6.6 Southeast Asia GLP-1 Weight Loss Drug Market Size, 2018-2029
6.6.7 India GLP-1 Weight Loss Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America GLP-1 Weight Loss Drug Revenue, 2018-2029
6.7.2 By Country – South America GLP-1 Weight Loss Drug Sales, 2018-2029
6.7.3 Brazil GLP-1 Weight Loss Drug Market Size, 2018-2029
6.7.4 Argentina GLP-1 Weight Loss Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa GLP-1 Weight Loss Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa GLP-1 Weight Loss Drug Sales, 2018-2029
6.8.3 Turkey GLP-1 Weight Loss Drug Market Size, 2018-2029
6.8.4 Israel GLP-1 Weight Loss Drug Market Size, 2018-2029
6.8.5 Saudi Arabia GLP-1 Weight Loss Drug Market Size, 2018-2029
6.8.6 UAE GLP-1 Weight Loss Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk GLP-1 Weight Loss Drug Major Product Offerings
7.1.4 Novo Nordisk GLP-1 Weight Loss Drug Sales and Revenue in Global (2018-2023)
7.1.5 Novo Nordisk Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca GLP-1 Weight Loss Drug Major Product Offerings
7.2.4 AstraZeneca GLP-1 Weight Loss Drug Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly GLP-1 Weight Loss Drug Major Product Offerings
7.3.4 Eli Lilly GLP-1 Weight Loss Drug Sales and Revenue in Global (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi GLP-1 Weight Loss Drug Major Product Offerings
7.4.4 Sanofi GLP-1 Weight Loss Drug Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 BENEMAE
7.5.1 BENEMAE Company Summary
7.5.2 BENEMAE Business Overview
7.5.3 BENEMAE GLP-1 Weight Loss Drug Major Product Offerings
7.5.4 BENEMAE GLP-1 Weight Loss Drug Sales and Revenue in Global (2018-2023)
7.5.5 BENEMAE Key News & Latest Developments
7.6 HANSOH PHARMLA
7.6.1 HANSOH PHARMLA Company Summary
7.6.2 HANSOH PHARMLA Business Overview
7.6.3 HANSOH PHARMLA GLP-1 Weight Loss Drug Major Product Offerings
7.6.4 HANSOH PHARMLA GLP-1 Weight Loss Drug Sales and Revenue in Global (2018-2023)
7.6.5 HANSOH PHARMLA Key News & Latest Developments
7.7 CHIATAI TIANQING
7.7.1 CHIATAI TIANQING Company Summary
7.7.2 CHIATAI TIANQING Business Overview
7.7.3 CHIATAI TIANQING GLP-1 Weight Loss Drug Major Product Offerings
7.7.4 CHIATAI TIANQING GLP-1 Weight Loss Drug Sales and Revenue in Global (2018-2023)
7.7.5 CHIATAI TIANQING Key News & Latest Developments
7.8 Tonghua Dongbao Pharmaceutical
7.8.1 Tonghua Dongbao Pharmaceutical Company Summary
7.8.2 Tonghua Dongbao Pharmaceutical Business Overview
7.8.3 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Major Product Offerings
7.8.4 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Sales and Revenue in Global (2018-2023)
7.8.5 Tonghua Dongbao Pharmaceutical Key News & Latest Developments
7.9 Huadong Medicine
7.9.1 Huadong Medicine Company Summary
7.9.2 Huadong Medicine Business Overview
7.9.3 Huadong Medicine GLP-1 Weight Loss Drug Major Product Offerings
7.9.4 Huadong Medicine GLP-1 Weight Loss Drug Sales and Revenue in Global (2018-2023)
7.9.5 Huadong Medicine Key News & Latest Developments
8 Global GLP-1 Weight Loss Drug Production Capacity, Analysis
8.1 Global GLP-1 Weight Loss Drug Production Capacity, 2018-2029
8.2 GLP-1 Weight Loss Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global GLP-1 Weight Loss Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GLP-1 Weight Loss Drug Supply Chain Analysis
10.1 GLP-1 Weight Loss Drug Industry Value Chain
10.2 GLP-1 Weight Loss Drug Upstream Market
10.3 GLP-1 Weight Loss Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 GLP-1 Weight Loss Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer